FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
Kawasaki disease (KD) is characterized by pediatric systemic vasculitis of an unknown cause. The low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A) gene was reported to be involved in the susceptibility of KD. DNA methylation is one of the epigenetic mechanisms that control gene expr...
Saved in:
| Main Authors: | Ho-Chang Kuo, Yu-Wen Hsu, Mei-Shin Wu, Peng Yeong Woon, Henry Sung-Ching Wong, Li-Jen Tsai, Ruo-Kai Lin, Sukhontip Klahan, Kai-Sheng Hsieh, Wei-Chiao Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/564625 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Chih-Jen Chen, et al.
Published: (2012-01-01) -
Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease
by: Chia-Yi Chin, MD, MS
Published: (2024-09-01) -
EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01) -
Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model
by: Gahao Chen, et al.
Published: (2025-01-01) -
Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01)